Logo (Actavis) 155 (Buprenorphine hydrochloride and naloxone hydrochloride 8 mg (base) / 2 mg (base))

Pill imprint Logo (Actavis) 155 has been identified as Buprenorphine hydrochloride and naloxone hydrochloride 8 mg (base) / 2 mg (base).

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.

See also related documents.

Images for Logo (Actavis) 155 (Buprenorphine hydrochloride and naloxone hydrochloride 8 mg (base) / 2 mg (base))

Buprenorphine hydrochloride and naloxone hydrochloride
Imprint:
Logo (Actavis)
155
Strength:
8 mg (base) / 2 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Actavis Elizabeth LLC
National Drug Code (NDC):
00228-3155
Inactive Ingredients:
citric acid anhydrous
crospovidone
lactose monohydrate
magnesium stearate
mannitol
corn starch
povidone
sodium citrate
sucralose

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)